More Information in the Adjuvant Chemoradiation Controversy for Pancreatic...
The findings of the European Study Group for Pancreatic Cancer (ESPAC-1) clinical trial and championed by surgeon John Neoptolemos of Liverpool University more than a decade ago challenged the...
View ArticleElectroporation for the Treatment of Locally Advanced Cancer of the Pancreas
Nilsson and colleagues from Uppsala University in Sweden in an interesting Phase I pilot study evaluated the irreversible electroporation procedure for the treatment of locally advanced (ostensibly...
View ArticleLocally Advanced Pancreatic Cancer: Induction Chemo with Whipple + Vascular...
In a certain way, the initial treatment considerations for local and advanced pancreatic cancer are not as complex as those of locally advanced adenocarcinoma of the pancreas. Local cancer is typically...
View ArticleLater Surgery for Advanced Pancreatic Cancer in Treatment Responders with...
Criteria for exclusion of patients from surgery for pancreatic cancer (ductal adenocarcinoma of the pancreas) include detection of distal metastases including those noted in the liver (also known as...
View ArticleNeoadjuvant Therapy in Stage 3 Pancreatic Cancer Confers Survival Advantage
In a certain sense, treatment selection by professionals is easier in early or late stage pancreatic cancer (ductal adenocarcinoma of the pancreas) because the options tend to be narrower: early yields...
View ArticleLong-term Results from Adjuvant Chemoradiation plus Interferon-α for...
The radiation component of adjuvant chemoradiation after surgery for ductal adenocarcinoma of the pancreas (pancreatic cancer) took a turn toward controversy beginning about year 2000 with results of...
View ArticleClik here to view.
Later Surgery for Advanced Pancreatic Cancer in Treatment Responders with...
Criteria for exclusion of patients from surgery for pancreatic cancer (ductal adenocarcinoma of the pancreas) include detection of distal metastases including those noted in the liver (also known as...
View ArticleNeoadjuvant Therapy in Stage 3 Pancreatic Cancer Confers Survival Advantage
In a certain sense, treatment selection by professionals is easier in early or late stage pancreatic cancer (ductal adenocarcinoma of the pancreas) because the options tend to be narrower: early yields...
View ArticleLong-term Results from Adjuvant Chemoradiation plus Interferon-α for...
The radiation component of adjuvant chemoradiation after surgery for ductal adenocarcinoma of the pancreas (pancreatic cancer) took a turn toward controversy beginning about year 2000 with results of...
View Article